Peter Grant

2.3k total citations
58 papers, 1.2k citations indexed

About

Peter Grant is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Peter Grant has authored 58 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Reproductive Medicine, 21 papers in Surgery and 19 papers in Obstetrics and Gynecology. Recurrent topics in Peter Grant's work include Ovarian cancer diagnosis and treatment (31 papers), Endometrial and Cervical Cancer Treatments (14 papers) and Intraperitoneal and Appendiceal Malignancies (10 papers). Peter Grant is often cited by papers focused on Ovarian cancer diagnosis and treatment (31 papers), Endometrial and Cervical Cancer Treatments (14 papers) and Intraperitoneal and Appendiceal Malignancies (10 papers). Peter Grant collaborates with scholars based in Australia, United Kingdom and Netherlands. Peter Grant's co-authors include John Pearn, Neville F. Hacker, Michael Quinn, Michael Friedländer, James Scurry, Simon Hyde, Anna DeFazio, David G. Allen, Norman A. Beischer and Penelope M. Webb and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and American Journal of Clinical Nutrition.

In The Last Decade

Peter Grant

58 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Grant Australia	21	517	359	359	266	208	58	1.2k
Dominik Denschlag Germany	23	860 1.7×	222 0.6×	744 2.1×	188 0.7×	333 1.6×	74	1.6k
Benjamin Merlot France	16	475 0.9×	176 0.5×	583 1.6×	177 0.7×	179 0.9×	86	1.1k
Daniela Luvero Italy	21	707 1.4×	359 1.0×	491 1.4×	261 1.0×	288 1.4×	66	1.4k
Alessandro Lucidi Italy	16	216 0.4×	197 0.5×	368 1.0×	154 0.6×	162 0.8×	47	742
Ron Auslender Israel	17	271 0.5×	264 0.7×	591 1.6×	92 0.3×	108 0.5×	68	1.2k
Hoa N. Nguyen United States	16	386 0.7×	212 0.6×	369 1.0×	185 0.7×	121 0.6×	37	866
Iordanis Navrozoglou Greece	15	219 0.4×	116 0.3×	262 0.7×	200 0.8×	98 0.5×	49	861
Frans J.M. Huikeshoven Netherlands	18	169 0.3×	255 0.7×	322 0.9×	99 0.4×	175 0.8×	51	972
Lee-may Chen United States	21	409 0.8×	203 0.6×	294 0.8×	803 3.0×	165 0.8×	41	1.6k
Ramon McGehee United States	15	259 0.5×	298 0.8×	567 1.6×	161 0.6×	98 0.5×	32	967

Countries citing papers authored by Peter Grant

Since Specialization

Citations

This map shows the geographic impact of Peter Grant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Grant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Grant more than expected).

Fields of papers citing papers by Peter Grant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Grant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Grant. The network helps show where Peter Grant may publish in the future.

Co-authorship network of co-authors of Peter Grant

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Grant. A scholar is included among the top collaborators of Peter Grant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Grant. Peter Grant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Majidi, Azam, Renhua Na, Susan J. Jordan, et al.. (2023). Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study. JNCI Journal of the National Cancer Institute. 115(5). 570–577. 6 indexed citations

Hiscock, Richard, et al.. (2021). Efficacy of dexamethasone in the management of malignant small bowel obstruction in advanced epithelial ovarian cancer. Supportive Care in Cancer. 30(3). 2821–2827. 5 indexed citations

Nagle, Christina M., Torukiri I Ibiebele, Peter Grant, et al.. (2020). Pre- and Post-Diagnosis Diet Quality and Ovarian Cancer Survival. Cancer Epidemiology Biomarkers & Prevention. 30(1). 229–232. 18 indexed citations

Mileshkin, Linda, Peter Grant, Anna DeFazio, et al.. (2020). Evaluating the impact of dose reductions and delays on progression-free survival in women with ovarian cancer treated with either three-weekly or dose-dense carboplatin and paclitaxel regimens in the national prospective OPAL cohort study. Gynecologic Oncology. 158(1). 47–53. 6 indexed citations

Tang, Mónica, Rachel O’Connell, Frédéric Amant, et al.. (2019). PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors. Gynecologic Oncology. 154(3). 531–538. 54 indexed citations

Friedländer, Michael, Madeleine King, Christina M. Nagle, et al.. (2018). Getting the most out of follow-up: A prospective study using the Measure of Ovarian Symptoms and Treatment concerns (MOST) symptom index to evaluate and track adverse effects (AEs) and detect symptoms of recurrence in patients with ovarian cancer (OC) following first line chemotherapy (1LT).. Journal of Clinical Oncology. 36(15_suppl). 10062–10062. 3 indexed citations

Lee, Yeh Chen, Mathias Bressel, Peter Grant, et al.. (2017). Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer. Familial Cancer. 16(4). 461–469. 2 indexed citations

Allen, David G., et al.. (2015). Adjuvant treatment, tumour recurrence and the survival rate of uterine serous carcinomas: a single-institution review of 62 women. 7(1). 14–20. 1 indexed citations

Mitchell, Paul, Michael Quinn, Peter Grant, et al.. (2014). A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer. Journal for ImmunoTherapy of Cancer. 2(1). 16–16. 29 indexed citations

10.

Blinman, Prunella, Mark W. Donoghoe, Julie Martyn, et al.. (2013). Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG study. Journal of Gynecologic Oncology. 24(4). 359–359. 14 indexed citations

11.

Allen, David G., et al.. (2011). Effects of Previous Surgery on the Detection of Sentinel Nodes in Women With Vulvar Cancer. International Journal of Gynecological Cancer. 21(9). 1679–1683. 12 indexed citations

12.

Kiely, Belinda E., Michael Friedländer, Roger L. Milne, et al.. (2011). Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer. Familial Cancer. 10(3). 505–514. 3 indexed citations

13.

Fons, Guus, Simon Hyde, Marrije R. Buist, et al.. (2009). Prognostic Value of Bilateral Positive Nodes in Squamous Cell Cancer of the Vulva. International Journal of Gynecological Cancer. 19(7). 1276–1280. 29 indexed citations

14.

Hyde, Simon, Susan Valmadre, Neville F. Hacker, et al.. (2006). Squamous cell carcinoma of the vulva with bulky positive groin nodes—nodal debulking versus full groin dissection prior to radiation therapy. International Journal of Gynecological Cancer. 17(1). 154–158. 38 indexed citations

15.

Armes, Jane E., Rohan Lourie, Melanie de Silva, et al.. (2005). Abnormalities of the RB1 Pathway in Ovarian Serous Papillary Carcinoma as Determined by Overexpression of the p16(INK4A) Protein. International Journal of Gynecological Pathology. 24(4). 363–368. 46 indexed citations

16.

Philip, Jennifer, Norelle Lickiss, Peter Grant, & Neville F. Hacker. (1999). Corticosteroids in the Management of Bowel Obstruction on a Gynecological Oncology Unit. Gynecologic Oncology. 74(1). 68–73. 24 indexed citations

17.

Quinn, Michael, Robert Rome, Peter Grant, & Robert S. Planner. (1991). High-dose medroxyprogesterone acetate in advanced ovarian cancer. International Journal of Gynecological Cancer. 1(5). 239–241. 4 indexed citations

18.

Scurry, James, Robert S. Planner, & Peter Grant. (1991). Unusual variants of vaginal adenosis: A challenge for diagnosis and treatment. Gynecologic Oncology. 41(2). 172–177. 11 indexed citations

19.

Grant, Peter, et al.. (1989). Pelvic radiation therapy for gynecologic malignancy in geriatric patients. Gynecologic Oncology. 33(2). 185–188. 21 indexed citations

20.

Landman, Jacqueline, Alun C. Jackson, Eleanor Wheeler, Peter Grant, & Janet McLeod. (1981). A Catch up Growth Chart. Journal of Tropical Pediatrics. 27(1). 47–51. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact